What should be included in trimester history according to latest update
trimester history obstetric antenatal history taking components 2024 2025
https://geekymedics.com/obstetric-history-taking
https://geekymedics.com/obstetric-history-taking
NICE antenatal care trimester history taking first second third 2023 2024 guidelines
| Item | Detail |
|---|---|
| LMP & EDD | Last menstrual period date; estimated date of delivery (Naegele's rule or US dating) |
| Dating ultrasound | Crown-rump length at 11-13+6 weeks; confirm singleton vs. multiple gestation; chorionicity if twins |
| Booking visit | Gestation at first antenatal contact (ideally by 10 weeks) |
| Combined screening | Nuchal translucency + PAPP-A + free β-hCG (11-13+6 weeks) for Down syndrome/trisomies; result and counselling given |
| Booking bloods | FBC, blood group & Rh type, red cell antibodies, rubella immunity, syphilis, HIV, hepatitis B, haemoglobin electrophoresis (if indicated) |
| Urine culture | Mid-stream urine for asymptomatic bacteriuria |
| Symptoms | Nausea/vomiting (hyperemesis gravidarum), bleeding (threatened miscarriage, implantation), pelvic pain |
| Folic acid | Whether 400 mcg (or 5 mg high-dose) was taken pre-conception and throughout first trimester |
| Pre-eclampsia risk assessment | NICE NG201: assessed at booking; aspirin 75-150 mg from 12 weeks if high risk |
| Medications & teratogen exposure | First trimester is the critical period for organogenesis |
| Smoking, alcohol, drugs | Social history assessed at booking |
| Item | Detail |
|---|---|
| Anatomy (anomaly) scan | 18-20+6 weeks - cardiac, neural tube, abdominal wall defects, renal anomalies, placental location |
| Fetal movements | Onset of quickening (typically 16-20 weeks); whether normal |
| Serum screening (if not done) | Quadruple test (AFP, hCG, uE3, inhibin A) at 14-20 weeks if combined test not done |
| Cervical length | In women with prior preterm birth; cervical incompetence screening |
| Glucose challenge/GDM screening | 24-28 weeks (OGTT); risk assessment reviewed |
| Blood pressure checks | At each visit; re-assess pre-eclampsia risk (NICE NG201 recommends second risk assessment in second trimester) |
| Urine protein | Dipstick at each visit |
| Amniocentesis or CVS | If chromosomal testing elected; result and follow-up |
| Vaccinations | Pertussis (whooping cough) vaccine offered 16-32 weeks (ideally 20 weeks) in UK |
| Growth and placenta review | Placenta previa check at 20 weeks - if low-lying, arrange rescan at 32 weeks |
| Symptoms | Bleeding, discharge, pelvic girdle pain (symphysis pubis dysfunction), reflux, oedema |
| Item | Detail |
|---|---|
| Growth scans | Symphysis-fundal height (SFH) plotted at every visit from 24 weeks; growth scans if concern |
| Repeat bloods | FBC and blood group antibodies at 28 weeks; haemoglobin to check for anaemia |
| Rh prophylaxis | Anti-D immunoglobulin at 28 (and 34) weeks if Rh negative |
| GBS screening | Vaginal/rectal swab at 36-37+6 weeks (ACOG recommendation) |
| Fetal presentation | Checked from 36 weeks; breech - offer ECV at 36+ weeks |
| Fetal movements | Any reduction reported; kick counts or formal monitoring |
| CTG / biophysical profile | If high-risk or post-term |
| Repeat HIV, syphilis, HBV | In high-risk patients (CDC recommends 28-36 weeks) |
| Blood pressure + proteinuria | Continued at every visit - pre-eclampsia surveillance |
| Planned mode of delivery | Vaginal vs. caesarean discussed; birth plan |
| Gestational diabetes management | Blood glucose monitoring, insulin if required |
| Placenta previa | If persisting at 32-week rescan, plan for elective C-section |
| Vitamin K & breastfeeding discussions | Antenatal counselling |
| Influenza vaccine | Offered at any gestation |
| Mental health | Screen for antenatal anxiety/depression at every trimester |